JP2004538253A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2004538253A5 JP2004538253A5 JP2002567295A JP2002567295A JP2004538253A5 JP 2004538253 A5 JP2004538253 A5 JP 2004538253A5 JP 2002567295 A JP2002567295 A JP 2002567295A JP 2002567295 A JP2002567295 A JP 2002567295A JP 2004538253 A5 JP2004538253 A5 JP 2004538253A5
- Authority
- JP
- Japan
- Prior art keywords
- taxane
- antitumor
- mode
- administration
- growth
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 229940123237 Taxane Drugs 0.000 claims 7
- 230000000259 anti-tumor effect Effects 0.000 claims 6
- DKPFODGZWDEEBT-QFIAKTPHSA-N taxane Chemical class C([C@]1(C)CCC[C@@H](C)[C@H]1C1)C[C@H]2[C@H](C)CC[C@@H]1C2(C)C DKPFODGZWDEEBT-QFIAKTPHSA-N 0.000 claims 6
- 230000002062 proliferating effect Effects 0.000 claims 4
- 210000004881 tumor cell Anatomy 0.000 claims 2
- 239000004480 active ingredient Substances 0.000 claims 1
- 238000011319 anticancer therapy Methods 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US27194401P | 2001-02-28 | 2001-02-28 | |
| PCT/US2002/005971 WO2002067928A2 (en) | 2001-02-28 | 2002-02-26 | Metronomic dosing of taxanes for inhibiting tumor growth |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2004538253A JP2004538253A (ja) | 2004-12-24 |
| JP2004538253A5 true JP2004538253A5 (https=) | 2005-12-22 |
Family
ID=23037749
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2002567295A Withdrawn JP2004538253A (ja) | 2001-02-28 | 2002-02-26 | タキサンのメトロノーム的な投与 |
Country Status (31)
| Country | Link |
|---|---|
| EP (1) | EP1372636B1 (https=) |
| JP (1) | JP2004538253A (https=) |
| KR (1) | KR20030086276A (https=) |
| CN (1) | CN1533273A (https=) |
| AR (1) | AR033609A1 (https=) |
| AT (1) | ATE331511T1 (https=) |
| BG (1) | BG108167A (https=) |
| BR (1) | BR0207519A (https=) |
| CA (1) | CA2439299A1 (https=) |
| CY (1) | CY1105468T1 (https=) |
| CZ (1) | CZ20032232A3 (https=) |
| DE (2) | DE60212813T2 (https=) |
| DK (1) | DK1372636T3 (https=) |
| EE (1) | EE200300413A (https=) |
| ES (1) | ES2211374T3 (https=) |
| HR (1) | HRP20030775A2 (https=) |
| HU (1) | HUP0402115A2 (https=) |
| IL (1) | IL157356A0 (https=) |
| IS (1) | IS6924A (https=) |
| MX (1) | MXPA03007655A (https=) |
| NO (1) | NO20033809L (https=) |
| PE (1) | PE20020955A1 (https=) |
| PL (1) | PL373376A1 (https=) |
| PT (1) | PT1372636E (https=) |
| RU (1) | RU2003129233A (https=) |
| SK (1) | SK10332003A3 (https=) |
| TR (1) | TR200400375T3 (https=) |
| UY (1) | UY27185A1 (https=) |
| WO (1) | WO2002067928A2 (https=) |
| YU (1) | YU66603A (https=) |
| ZA (1) | ZA200306450B (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6750246B1 (en) | 2000-02-03 | 2004-06-15 | Bristol-Myers Squibb Company | C-4 carbonate taxanes |
| WO2005039533A1 (en) * | 2003-10-15 | 2005-05-06 | Medigene Ag | Method of administering cationic liposomes comprising an active drug |
| EP1896007B1 (en) | 2005-05-04 | 2014-03-19 | Medigene AG | Method of administering a cationic liposomal preparation comprising paclitexel |
| BRPI0709075A2 (pt) | 2006-03-20 | 2011-10-11 | Medigene Ag | tratamento de cáncer de mama triplo receptor negativo |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1261275A (zh) * | 1997-05-27 | 2000-07-26 | 巴克·诺顿药物有限公司 | 给予病人口服紫杉烷类药物的方法和组合物 |
| US6750246B1 (en) * | 2000-02-03 | 2004-06-15 | Bristol-Myers Squibb Company | C-4 carbonate taxanes |
| US6362217B2 (en) * | 2000-03-17 | 2002-03-26 | Bristol-Myers Squibb Company | Taxane anticancer agents |
-
2002
- 2002-02-25 UY UY27185A patent/UY27185A1/es not_active Application Discontinuation
- 2002-02-26 CZ CZ20032232A patent/CZ20032232A3/cs unknown
- 2002-02-26 CN CNA028090306A patent/CN1533273A/zh active Pending
- 2002-02-26 HR HR20030775A patent/HRP20030775A2/hr not_active Application Discontinuation
- 2002-02-26 CA CA002439299A patent/CA2439299A1/en not_active Abandoned
- 2002-02-26 ES ES02723255T patent/ES2211374T3/es not_active Expired - Lifetime
- 2002-02-26 EE EEP200300413A patent/EE200300413A/xx unknown
- 2002-02-26 KR KR10-2003-7011251A patent/KR20030086276A/ko not_active Withdrawn
- 2002-02-26 DE DE60212813T patent/DE60212813T2/de not_active Expired - Fee Related
- 2002-02-26 YU YU66603A patent/YU66603A/sh unknown
- 2002-02-26 WO PCT/US2002/005971 patent/WO2002067928A2/en not_active Ceased
- 2002-02-26 SK SK1033-2003A patent/SK10332003A3/sk not_active Application Discontinuation
- 2002-02-26 RU RU2003129233/14A patent/RU2003129233A/ru not_active Application Discontinuation
- 2002-02-26 MX MXPA03007655A patent/MXPA03007655A/es unknown
- 2002-02-26 TR TR200400375T patent/TR200400375T3/xx unknown
- 2002-02-26 EP EP02723255A patent/EP1372636B1/en not_active Expired - Lifetime
- 2002-02-26 JP JP2002567295A patent/JP2004538253A/ja not_active Withdrawn
- 2002-02-26 DK DK02723255T patent/DK1372636T3/da active
- 2002-02-26 PL PL02373376A patent/PL373376A1/xx not_active Application Discontinuation
- 2002-02-26 AT AT02723255T patent/ATE331511T1/de not_active IP Right Cessation
- 2002-02-26 HU HU0402115A patent/HUP0402115A2/hu unknown
- 2002-02-26 IL IL15735602A patent/IL157356A0/xx unknown
- 2002-02-26 DE DE0001372636T patent/DE02723255T1/de active Pending
- 2002-02-26 PT PT02723255T patent/PT1372636E/pt unknown
- 2002-02-26 BR BR0207519-9A patent/BR0207519A/pt not_active IP Right Cessation
- 2002-02-27 AR ARP020100688A patent/AR033609A1/es unknown
- 2002-02-27 PE PE2002000165A patent/PE20020955A1/es not_active Application Discontinuation
-
2003
- 2003-08-19 ZA ZA200306450A patent/ZA200306450B/xx unknown
- 2003-08-22 IS IS6924A patent/IS6924A/is unknown
- 2003-08-27 NO NO20033809A patent/NO20033809L/no unknown
- 2003-09-09 BG BG108167A patent/BG108167A/xx unknown
-
2006
- 2006-09-21 CY CY20061101360T patent/CY1105468T1/el unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2356547C2 (ru) | Способы лечения рака с использованием ингибиторов hdac | |
| JP2006515883A5 (https=) | ||
| IL273765A (en) | Combinations and forms of administration of therapeutic agents and combined treatment | |
| JP2019515908A5 (https=) | ||
| JP2005500357A5 (https=) | ||
| RU2325389C2 (ru) | Композиция и производные замещенного азаиндолоксоацетапиперазина, обладающие противовирусной активностью | |
| JP2006523216A5 (https=) | ||
| EP1623985A3 (en) | Analogs of indole-3-carbinol metabolites as chemotherapeutic and chemopreventative agents | |
| JP2005525345A5 (https=) | ||
| RU2008122358A (ru) | Лекарственные формы, содержащие ag013736 | |
| JP2005511597A5 (https=) | ||
| PT1383752E (pt) | 3-piperidinopropiofenonas deuteradas assim como farmacos contendo estes compostos | |
| JP2008510758A5 (https=) | ||
| JP2007506801A5 (https=) | ||
| JP2005500277A5 (https=) | ||
| ATE398441T1 (de) | Octenidinhaltige lutschtabletten gegen entzündliche erkrankungen des mund- und rachenraums | |
| CO5251425A1 (es) | Metodo y composiciones para administrar taxanos oralmente a pacientes humanos | |
| JP2003514025A5 (https=) | ||
| JP2009510165A5 (https=) | ||
| JP2004538253A5 (https=) | ||
| JP2003511396A5 (https=) | ||
| EA200600377A1 (ru) | Новая композиция | |
| JP2004506605A5 (https=) | ||
| JP2004521140A5 (https=) | ||
| JP2005509663A5 (https=) |